FYI | Sep 05 2014
By Rudi Filapek-Vandyck, Editor FNArena
I like to question the ruling logic that goads the herd, or at the very least stimulate independent thinking. There's a big difference between playing market momentum as a short term trader and trying to figure out what the best asset purchases are for longer term investing.
Since 2012 I maintain my own feed of quotes, comments, responses and market insights via Twitter. Not everyone is on Twitter, which explains the requests to make my Twitter items also available through the newsfeed on the FNArena website.
Usually I combine all Tweets from the week past in one weekly story. Below are my Tweets from the week past. Enjoy.
Investors can follow me on Twitter via @filapek
****
– FY14 reporting season delivered highest growth since 2007, but it was merely confirmation of market expectations http://tiny.cc/1ewolx
– UBS sees risk to downside #ironore in short term but Nov-Dec should see bounce, estimates 25% of global supply might be loss-making #ausbiz
– Returning from Beijing trip, Citi analysts report #China's self-sustained GDP growth rate now 6.5-7.0%; prepare for new normal #ausbiz
– Citi suggests investors should prepare for wave of M&A inside Australian media sector. Sees NSW, SWM and NEC best placed #ausbiz
– Overnight: US #equities down. #Oil down. #Gold down. Base #metals higher. #ironore down US$1.40 to US$84.30/t. A$ US93.50c #ausbiz
– A gloating Goldman Sachs issues "Told you so" research update on #ironore. Maintains forecast for US$80/tonne average in 2015 #ausbiz
– Morgan Stanley retains 5800 target for ASX200 year-end, sees both banks and resources struggling to outperform #ausbiz
– It's not all Buys. Credit Suisse initiates coverage on Healthscope with Neutral and $2.50 target. Deutsche Bank sits on Neutral too #ausbiz
– UBS initiates coverage on Healthscope with Buy rating and price target of $2.70 #ausbiz
– Overnight: US #equities stable. #Oil bounces. #Gold up. Base #metals mixed, #nickel up. #ironore falls to US$85.70/t. A$ US93.44c #ausbiz
– Goldman Sachs has initiated coverage on Healthscope with Buy rating and $2.40 price target #ausbiz
– BA-ML initiated coverage on Healthscope with Buy rating and $2.60 price target #ausbiz
– This could well turn out the longest expansion for US economy and #equities ever, muses Morgan Stanley. S&P500 at 3000 in 5 years? #ausbiz
– Technical analysis by RBC suggests investors should hold defensive bias as US #equities approach top end of 3-year rising channel #ausbiz
– Overnight: US #equities lacklustre.#Oil lower. #Gold lower. Base #metals mixed. #Ironore continues its slide, now at US$86.70/t. A$ US92.76c
– The Origin Re-rating has arrived, declares Morgan Stanley. Upgrade to Overweight (Industry In-Line), price target lifted to $18.50 #ausbiz
– #China needs more stimulus, says ANZ Bank, with PMI surveys and data pointing at deceleration in momentum, again. 7.5% growth target at risk
– Friday's action: US #equities up, but closed today. #Oil up. #Gold down. Base #metals up. #ironore up at US$87.90/t. A$ US93.39c #ausbiz
You can add my regular Tweets on Twitter via @filapek
Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" – Warning this story contains unashamedly positive feedback on the service provided.
